Fundraising Fox

Stephen Knight

Investor

President and Managing Partner at F-Prime Capital Partners

Cambridge, Massachusetts

Writes $100K – $10M checks · typically $5M

About

Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.

LinkedIn ↗

Invests in

BiotechCrypto & Web3FintechHealthtechMedical Devices

Experience

  1. F-Prime Capital (formerly Fidelity Biosciences)President & Senior Managing Partnercurrent2003 — presentCambridge, MA
  2. EPIX PharmaceuticalsPresident, COO1996 — 2003Cambridge, MA
  3. Arthur D. LittleConsultant1991 — 1996Cambridge, MA
  4. AT&T Bell LaboratoriesResearcher1985Murray Hill

Education

  1. Yale School of MedicineMD1985 — 1990
  2. Yale School of ManagementMBA1988 — 1990
  3. Columbia UniversityBS, Biology1981 — 1983

Skills & more

Strategy6Mergers & Acquisitions1Biotechnology3Start-ups13Venture Capital7Due Diligence2Entrepreneurship3Life Sciences1Business Strategy2Pharmaceutical Industry3

From Stephen's professional profile.

Same school

Also attended Yale School of Medicine23

Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMax FarinaPrincipal at 5AM VenturesBrian YordyPrincipal at F-Prime Capital PartnersDr. Tom HawesInvestor at Sandbox Industries

+ 17 more

Also attended Yale School of Management112

Sanjot MalhiPartner at NorthzoneTrip HoferVenture Partner at .406 VenturesAustin KwounAnalyst at .406 VenturesNate WangVP of Investments at Plum Alley InvestmentsGabby CazeauInvestor at Harlem Capital PartnersRob BettigoleManaging Partner at Elm Street Ventures

+ 106 more

Also attended Columbia University498

Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)Erica VanInvestment Director at Intel Capital

+ 492 more

Shared employers

Also worked at EPIX Pharmaceuticals2

Pini OrbachManaging Partner at Arkin CapitalSharon ShachamManaging Partner at E44 Ventures

Also worked at Arthur D. Little38

Josh BreinlingerVenture Partner at FJ LabsKevin KopczynskiPartner at Congruent VenturesMatthew WalshFounding Partner at Castle Island VenturesJason ScottAccelerator Operations at Blockchain BuildersVivian HadisManaging Principal, General Counsel and Chief Compliance Officer at Odyssey Investment PartnersGonzalo Sánchez-ArjonaInvestment Director at Kibo Ventures

+ 32 more

Deals · 1

Ensoma, Inc.Board seat

via F-Prime Capital Partners · filed Jan 2023 · $79M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at F-Prime Capital Partners

Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Alexander Pasteur
Partner at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners

Network1

Eli Casdin
Chief Investment Officer and Founder at Casdin Capital

Investors connected to Stephen in public investor directories — a warm-intro map.